Plasmon-Activated Water Decreases Vasculopathy in Orthotopic Allograft Transplantation Rats

Patients undergoing orthotopic allograft transplantation (OAT) will certainly suffer from vasculopathy. Although there are many immunosuppressive and immunomodulatory agents that are administered to patients, chronic rejection- induced vasculopathy cannot be entirely managed. Moreover, the implanted graft might become dysfunctional. In the past, we have used deionized reverse osmosis water (ROW) to stream via gold nanoparticles (AuNPs) at room temperature under powerful illumination, in order to prepare plasmon-activated water (PAW) with fewer hydrogen bonds. Compared to ROW, stable PAW can successfully remove free hydroxyl and 2,2-diphenyl-1-picrylhydrazyl radicals, and efficiently reduce lipopolysaccharide (LPS)-induced monocytes to release nitric oxide. Moreover, PAW can considerably induce the expression of the antioxidant gene Nrf2 in human gingival fibroblasts. Moreover, it might lower amyloid burden in mice with Alzheimer's disease. Furthermore, PAW decreased metastasis in mice grafted with Lewis lung carcinoma cells and boosted the overall survival in combination with cisplatin. Because of this possibility that PAW could prevent systemic disease, we aimed to evaluate the influence of PAW on OAT-induced vasculopathy. Here, we demonstrated that daily intake of PAW lowered the progression of vasculopathy in OAT-recipient ACI/NKyo rats by inhibiting collagen accumulation, proliferation of smooth muscle cells and fibroblasts, and T lymphocyte infiltration in the vessel wall. Moreover, the results showed reduced T and B lymphocytes, plasma cells, and macrophage activation in the spleen of the OAT-recipient ACI/NKyo rats that were administered PAW. Finally, in contrast to the control group, the OAT-recipient ACI/NKyo rats that were administered PAW exhibited higher mobilization and levels of circulating endothelial progenitor cells associated with vessel repair. Therefore, this study highlights the therapeutic roles of PAW in vasculopathy.

[1]  I. Hsiao,et al.  Plasmon-Activated Water Reduces Amyloid Burden and Improves Memory in Animals with Alzheimer’s Disease , 2019, Scientific Reports.

[2]  H. Woodrow,et al.  : A Review of the , 2018 .

[3]  L. Vay,et al.  Maternal Trophic Status and Offpsring Phenotype in a Marine Invertebrate , 2018, Scientific Reports.

[4]  N. Del Papa,et al.  The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis , 2018, Front. Immunol..

[5]  Yu-Chuan Liu,et al.  Therapeutics for Inflammatory-Related Diseases Based on Plasmon-Activated Water: A Review , 2018, International journal of molecular sciences.

[6]  C. Tai,et al.  Innovatively Therapeutic Strategy on Lung Cancer by Daily Drinking Antioxidative Plasmon-Induced Activated Water , 2018, Scientific Reports.

[7]  Dawei Wang,et al.  Boosting Hot Electrons in Hetero-superstructures for Plasmon-Enhanced Catalysis. , 2017, Journal of the American Chemical Society.

[8]  C. Shih,et al.  Multifunctions of Excited Gold Nanoparticles Decorated Artificial Kidney with Efficient Hemodialysis and Therapeutic Potential. , 2016, ACS Applied Materials and Interfaces.

[9]  V. Fuster,et al.  Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability , 2016, Nature Communications.

[10]  B. Hwang,et al.  Creation of Electron-doping Liquid Water with Reduced Hydrogen Bonds , 2016, Scientific Reports.

[11]  Po-Wei Tsai,et al.  Effective Energy Transfer via Plasmon-Activated High-Energy Water Promotes Its Fundamental Activities of Solubility, Ionic Conductivity, and Extraction at Room Temperature , 2015, Scientific Reports.

[12]  D. McGavern,et al.  Elucidation of monocyte/macrophage dynamics and function by intravital imaging , 2015, Journal of leukocyte biology.

[13]  Liang-Yih Chen,et al.  Quantitative evaluation on activated property-tunable bulk liquid water with reduced hydrogen bonds using deconvoluted Raman spectroscopy. , 2015, Analytical chemistry.

[14]  R. Iftimie,et al.  Donor-Bridge-Acceptor Proton Transfer in Aqueous Solution. , 2014, The journal of physical chemistry letters.

[15]  J. Pober,et al.  Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy. , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[16]  P. Xiong,et al.  HMGB1 Is Involved in Chronic Rejection of Cardiac Allograft via Promoting Inflammatory‐Like mDCs , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  K. Voı̈tchovsky,et al.  Water-induced correlation between single ions imaged at the solid–liquid interface , 2014, Nature Communications.

[18]  Chun-Chao Chang,et al.  Innovative strategy with potential to increase hemodialysis efficiency and safety , 2014, Scientific Reports.

[19]  S. Reddy,et al.  Reactive oxygen species in inflammation and tissue injury. , 2014, Antioxidants & redox signaling.

[20]  De‐Yin Wu,et al.  Activation of oxygen on gold and silver nanoparticles assisted by surface plasmon resonances. , 2014, Angewandte Chemie.

[21]  B. Hwang,et al.  Active and stable liquid water innovatively prepared using resonantly illuminated gold nanoparticles. , 2014, ACS nano.

[22]  I. Arends,et al.  Photobiocatalytic chemistry of oxidoreductases using water as the electron donor , 2014, Nature Communications.

[23]  Josef Stehlik,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report--2013; focus theme: age. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  Florian Libisch,et al.  Hot electrons do the impossible: plasmon-induced dissociation of H2 on Au. , 2013, Nano letters.

[25]  Daniel G. Anderson,et al.  FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. , 2012, Cell reports.

[26]  W. Pu,et al.  Endocardial and Epicardial Epithelial to Mesenchymal Transitions in Heart Development and Disease , 2012, Circulation research.

[27]  S. Jimenez,et al.  Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases , 2012, Fibrogenesis & tissue repair.

[28]  V. Fuster,et al.  Epithelial-to-Mesenchymal and Endothelial-to-Mesenchymal Transition: From Cardiovascular Development to Disease , 2012, Circulation.

[29]  M. Mubarak,et al.  Antibody-mediated rejection: Importance of lactate dehydrogenase and neutrophilia in early diagnosis. , 2011, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[30]  M. Fishbein,et al.  HLA and MICA: Targets of Antibody-Mediated Rejection in Heart Transplantation , 2011, Transplantation.

[31]  V. Rao,et al.  Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[32]  T. Mohanakumar,et al.  Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection , 2010, Current opinion in organ transplantation.

[33]  O. Rimoldi,et al.  Progenitor Cells From the Explanted Heart Generate Immunocompatible Myocardium Within the Transplanted Donor Heart , 2009, Circulation research.

[34]  P. Chowienczyk,et al.  Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells. , 2009, British journal of clinical pharmacology.

[35]  M. Gladwin,et al.  Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions , 2009, American journal of hematology.

[36]  J. Lordan,et al.  Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation , 2009, Thorax.

[37]  B. McManus,et al.  Allograft vasculopathy versus atherosclerosis. , 2006, Circulation research.

[38]  N. de Jonge,et al.  The Chemokine and Chemokine Receptor Profile of Infiltrating Cells in the Wall of Arteries With Cardiac Allograft Vasculopathy Is Indicative of a Memory T–Helper 1 Response , 2006, Circulation.

[39]  A. Avogaro,et al.  Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[40]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[41]  K. Tracey,et al.  High Mobility Group Box Protein 1: An Endogenous Signal for Dendritic Cell Maturation and Th1 Polarization , 2004, The Journal of Immunology.

[42]  M. Goddard,et al.  Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[43]  E. Abraham,et al.  Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein* , 2004, Journal of Biological Chemistry.

[44]  Tiziana Bonaldi,et al.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.

[45]  J. Palmblad,et al.  High mobility group 1 B‐box mediates activation of human endothelium , 2003, Journal of internal medicine.

[46]  E. Reis,et al.  Cold ischemic injury, aortic allograft vasculopathy, and pro-inflammatory cytokine expression. , 2003, The Journal of surgical research.

[47]  Arjun Deb,et al.  Endothelial Progenitor Cells Are Decreased in Blood of Cardiac Allograft Patients With Vasculopathy and Endothelial Cells of Noncardiac Origin Are Enriched in Transplant Atherosclerosis , 2003, Circulation.

[48]  J. Hillebrands,et al.  Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[49]  P. Butterworth,et al.  The effect of guar galactomannan and water availability during hydrothermal processing on the hydrolysis of starch catalysed by pancreatic alpha-amylase. , 2002, Biochimica et biophysica acta.

[50]  B. Meiser,et al.  Modulation of coronary vasomotor tone by cytokines in cardiac transplant recipients. , 1999, Transplantation.

[51]  L. de Meis,et al.  Role of water activity on the rates of acetyl phosphate and ATP hydrolysis , 1988, FEBS letters.

[52]  Jian Zhang,et al.  Boosting electrocatalytic hydrogen evolution by plasmon-driven hot-electron excitation. , 2018, Nanoscale.

[53]  D. Zurakowski,et al.  VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[54]  T. Mohanakumar,et al.  Mechanisms of chronic cardiac allograft rejection. , 2013, Texas Heart Institute journal.

[55]  David O. Taylor,et al.  Evolving Concepts and Treatment Strategies for Cardiac Allograft Vasculopathy , 2013, Current Treatment Options in Cardiovascular Medicine.

[56]  A. Haleem,et al.  Antibody-mediated rejection: importance of lactate dehydrogenase and neutrophilia in early diagnosis. , 2011, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[57]  M. Weiss,et al.  Mechanisms of chronic rejection in cardiothoracic transplantation. , 2008, Frontiers in bioscience : a journal and virtual library.

[58]  J. Pober,et al.  Interferon-gamma axis in graft arteriosclerosis. , 2007, Circulation research.

[59]  J. Hillebrands,et al.  Role of progenitor cells in transplant arteriosclerosis. , 2005, Trends in cardiovascular medicine.

[60]  K. Tracey,et al.  IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. , 2003, Journal of immunology.

[61]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.

[62]  B. Ballermann,et al.  TGF-beta and the endothelium during immune injury. , 1997, Kidney international.